Financhill
Back

Cytek Biosciences Quote, Financials, Valuation and Earnings

Cytek Biosciences Price Quote

$6.21

Cytek Biosciences Key Stats

Buy
63
Cytek Biosciences (CTKB) is a Buy

Day range:
$6.11 - $6.43
52-week range:
$4.66 - $9.87
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.08
P/B ratio:
2.08%

Volume:
537.2K
Avg. volume:
820.6K
1-year change:
-22.57%
Market cap:
$799.9M
Revenue:
$193M
EPS:
$-0.08

How Much Does Cytek Biosciences Make?

Is Cytek Biosciences Growing As A Company?

  • What Is Cytek Biosciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.07%
  • What Is Cytek Biosciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Cytek Biosciences Stock Price Performance

  • Did Cytek Biosciences Stock Go Up Last Month?
    Cytek Biosciences share price went down by -8.41% last month
  • Did CTKB's Share Price Rise Over The Last Year?
    CTKB share price fell by -22.57% over the past 1 year

What Is Cytek Biosciences 52-Week High & Low?

Cytek Biosciences Price To Free Cash Flow

Is It Risky To Buy Cytek Biosciences?

  • How Much Debt Does Cytek Biosciences Have?
    Total long term debt quarterly is $3.2M
  • How Much Cash Does Cytek Biosciences Have?
    Cash and short term investments quarterly total is $277.8M
  • What Is Cytek Biosciences’s Book Value Per Share?
    Book value per share is 2.97

Is Cytek Biosciences Cash Flow Positive?

  • What Is CTKB Cash Flow From Operations?
    Cash flow from operations (TTM) is $32.9M
  • What Is Cytek Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$45.9M
  • What Is Cytek Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $9.5M

Cytek Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    CTKB return on invested capital is -2.55%
  • What Is Cytek Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is -2.05%
  • What Is CTKB Return On Equity?
    ROE is a measure of profitability and is -2.57%

Cytek Biosciences Earnings Date & Stock Price

Cytek Biosciences Competitors

Cytek Biosciences Dividend Yield

Cytek Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 52.17%
Revenue: 7.29% 1.59%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 8.40
Upside from Last Price: 35.27%

Major Shareholders

  • How many CTKB shares are owned by institutional investors?
    119.8M CTKB shares are owned by institutional investors
  • How many CTKB shares are owned by insiders?
    11.5M CTKB shares are owned by insiders